Efficacy of Olfactory and Pareidolia Tests Compared With That of Indicative Biomarkers in Diagnosis of Dementia With Lewy Bodies

Efficacy of Olfactory and Pareidolia Tests Compared With That of Indicative Biomarkers in Diagnosis of Dementia With Lewy Bodies

Purpose: Although olfactory decline and visual hallucinations are useful in distinguishing dementia with Lewy bodies (DLB) from Alzheimer's disease (AD) in a clinical setting, neither is easy to evaluate objectively. The pareidolia test is used to assess susceptibility to visual hallucinations,...

Full description

Bibliographic Details
Main Authors: Yuta Inagawa, Hidekazu Kanetaka, Akito Tsugawa, Shu Sakurai, Shuntaro Serisawa, Soichiro Shimizu, Hirofumi Sakurai, Haruo Hanyu
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Neurology
Subjects:
MIBG cardiac scintigraphy
DAT (dopamine transporter)
pareidolia test
OSIT-J
AD
DLB
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2020.540291/full

Internet

https://www.frontiersin.org/article/10.3389/fneur.2020.540291/full

Similar Items